Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Neural Therapeutics Inc. ( (TSE:NURL) ).
Neural Therapeutics Inc. has amended its strategic investment and option agreement with CWE European Holdings Inc., shifting the structure of a previously announced concurrent financing from an equity private placement in a new subsidiary to a non-brokered private placement of up to $1 million in unsecured convertible debentures issued directly by CWE. The debentures carry a 9% annual interest rate, a 24‑month maturity, and are convertible into shares of the resulting issuer at $0.12 per share, with the resulting issuer retaining prepayment rights and the ability to force conversion if trading conditions are met, subject to Canadian Securities Exchange and other regulatory approvals.
The company also rescheduled its annual and special shareholder meeting to May 25, 2026, with all agenda items unchanged, including approval of the Series B transactions tied to the CWE deal. In addition, Neural granted 1.8 million immediately vesting restricted share units to certain directors and officers under its equity incentive plan, reinforcing management incentives as it advances its European expansion and mental health drug development strategy.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is an ethnobotanical drug discovery company developing therapeutic drugs for mental health conditions related to substance use disorders, including alcohol and opioid dependence. Its strategy centers on sub-hallucinogenic doses of mescaline extract to improve safety and scalability while maintaining therapeutic efficacy, and it is expanding its European commercial footprint through a multi-stage transaction to potentially acquire German CBD and hemp retailer CWE European Holdings Inc., which operates as Hanf.com.
Average Trading Volume: 106,237
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$1.69M
For an in-depth examination of NURL stock, go to TipRanks’ Overview page.